Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04241185 |
|---|---|
| Brief Title: | Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) |
| First Submitted : | January 22, 2020 |
| First Submitted that Met QC Criteria : | January 22, 2020 |
| First Posted : | January 27, 2020 |
| Last Update Submitted that Met QC Criteria : | May 9, 2024 |
| Last Update Posted : | May 10, 2024 |